|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 6 691-700, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
S Russo, D Tomatis, G Collo, G Tarone and F Tato
Istituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Biologia Cellulare e dello Sviluppo, Universita di Roma 'La Sapienza', Italy.
Myogenic regulatory factors (MRF) of the MyoD family regulate the skeletal muscle differentiation program. Non-muscle cells transfected with exogenous MRF either are converted to the myogenic lineage or fail to express the muscle phenotype, depending on the cell type analysed. We report here that MRF-induced myogenic conversion of NIH3T3 cells results in an incomplete reprogramming of these cells. Transfected cells withdrew from the cell cycle and underwent biochemical differentiation but, surprisingly, terminally differentiated myocytes absolutely failed to fuse into multinucleated myotubes. Analysis of muscle regulatory and structural gene expression failed to provide an explanation for the fusion defectiveness. However, myogenic derivatives of NIH3T3 cells were shown to be unable to accumulate the transcripts encoding muscle-specific isoforms of the integrin subunit beta1D and the transcription factor MEF2D1b2, that depend on muscle-specific alternative splicing. Our results suggest that the fusion into myotubes is under a distinct genetic control that might depend, at least partially, on differential splicing.
This article has been cited by other articles:
![]() |
J. M. Lingbeck, J. S. Trausch-Azar, A. Ciechanover, and A. L. Schwartz In vivo interactions of MyoD, Id1, and E2A proteins determined by acceptor photobleaching fluorescence resonance energy transfer FASEB J, June 1, 2008; 22(6): 1694 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Torrente, J.-P Tremblay, F. Pisati, M. Belicchi, B. Rossi, M. Sironi, F. Fortunato, M. El Fahime, M. G. D'Angelo, N. J. Caron, et al. Intraarterial Injection of Muscle-derived CD34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice J. Cell Biol., January 22, 2001; 152(2): 335 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Torrente, M.G. D'Angelo, Z. Li, R. Del Bo, S. Corti, M. Mericskay, A. DeLiso, A. Fassati, D. Paulin, G.P. Comi, et al. Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiency Hum. Mol. Genet., July 22, 2000; 9(12): 1843 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. GORZA and M. VITADELLO Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence FASEB J, March 1, 2000; 14(3): 461 - 475. [Abstract] [Full Text] |
||||
![]() |
J. Larrain, D. J. Carey, and E. Brandan Syndecan-1 Expression Inhibits Myoblast Differentiation through a Basic Fibroblast Growth Factor-dependent Mechanism J. Biol. Chem., November 27, 1998; 273(48): 32288 - 32296. [Abstract] [Full Text] [PDF] |
||||